Guggenheim Capital LLC Spectrum Pharmaceuticals Inc Transaction History

Guggenheim Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$7.03 - $9.7 $1.19 Million - $1.64 Million	-168,956 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$7.36 - $11.26 $9,361 - $14,322	1,272 Added 0.76%	168,956 $1.46 Million
Q1 2019 May 15, 2019	BUY	$9.08 - $11.84 $110,585 - $144,199	12,179 Added 7.83%	167,684 $1.79 Million
Q4 2018 Feb 14, 2019	BUY	$6.39 - $16.99 $141,800 - $377,025	22,191 Added 16.65%	155,505 $1.36 Million
Q3 2018 Nov 14, 2018	SELL	$16.52 - $24.82 $29,422 - $44,204	-1,781 Reduced 1.32%	133,314 $2.24 Million

Q2 2018 Aug 14, 2018	BUY	$14.31 - $21.75 $69,661 - $105,879	4,868 Added 3.74%	135,095 $2.83 Million
Q1 2018 May 15, 2018	SELL	$16.09 - $23.07 $27,143 - $38,919	-1,687 Reduced 1.28%	130,227 $2.1 Million
Q4 2017 Feb 14, 2018	BUY	$13.36 - $20.73 $1.76 Million - $2.73 Million	131,914	131,914 $2.5 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.